Nvidia’s biotech moment; Regeneron launches venture arm; New GLP-1 player enters; Sanofi rejigs cancer pact, vaccine ops; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.

Next month, we will be partnering with the Financial Times on its US Pharma and Biotech Summit returns to New York. There are options for both in-person and virtual attendance — you can find the speakers and agenda here.

Nvidia’s biotech moment

Over the last decade, multiple tech giants have tried and failed to get into healthcare. Nvidia, though, appears to be the exception. Is this finally tech’s healthcare moment? Andrew Dunn takes a deep dive into the chipmaker’s plan to dominate biotech’s AI revolution.

Regeneron launches venture arm

Regeneron is getting…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks